Author: MGSN

HOUSTON, TX, Sept. 25, 2025 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the ā€œCompanyā€ or ā€œNexalinā€), the leader in Deep Intracranial Frequency Stimulation (DIFSā„¢) of the brain, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Design Patent No. D1,092,758, entitled Transcranial Electro-Stimulation Device, providing 15 years of design protection for the Company’s next-generation HALOā„¢ Clarity neuromodulation device. HALOā„¢ Clarity isRead More

Read More